Radiation revolutionized medicine when it was first used to treat cancer in 1901. Its use, however, has only been able to evolve as far as technical innovation has allowed.
All news from Forensic Medicine & Toxicology
Researchers are using artificial intelligence to reduce the dose of a contrast agent that may be left behind in the body after MRI exams, according to a study being presented today at the annual meeting of the Radiological Society of North America (RSNA).
The Federal Court has ruled that the encapsulation in Australia of imported fish oil and Vitamin D by Nature’s Care Manufacture Pty Ltd (Nature’s Care) would not permit the capsules to be labeled ‘Made in Australia’ under the Australian Consumer Law’s (ACL) Country of Origin labeling provisions.
Researchers have identified distinguishing clinical features of the polio-like disease acute flaccid myelitis (AFM), a new report shows. They propose a more restrictive definition of the disease to help identify cases more quickly and to differentiate such cases from those of other illnesses that can cause acute weakness.
Stem cell transplantation is effective against leukemia. In many cases, however, the transferred immune cells of the donor also attack the recipients' healthy tissue—often with fatal consequences. Researchers at the University of Zurich have now identified a molecule that plays a key role in this process.
After struggling with depression since adolescence, California native Cameron Underwood spent a June 2016 day drinking, placed a shotgun under his chin and pulled the trigger. The blast destroyed much of his face and began a journey that led to the most advanced face transplant surgery ever performed.
A targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS. Regorafenib (Stivarga) is to be offered to people with advanced liver cancer in England and Wales who can't have surgery and have already been treated with another drug called sorafenib (Nexavar).